The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Buerger’s Disease Diagnosis Market Research Report 2024
Synopsis
The global Buerger’s Disease Diagnosis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Buerger’s Disease Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Buerger’s Disease Diagnosis.
Report Scope
The Buerger’s Disease Diagnosis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Buerger’s Disease Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Buerger’s Disease Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
FUJIFILM Holdings
GE Healthcare
Koninklijke Philips
Pluristem Therapeutics
Shimadzu Corporation
Siemens Healthcare GmbH
Stempeutics Research
Canon Medical Systems Corporation
t2cure GmbH
Segment by Type
Blood Tests
The Allen’s Test
Angiogram
Tissue Biopsy
Others
Segment by Application
Hospitals
Clinics
Medical Research Centers
Academic Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Buerger’s Disease Diagnosis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Buerger’s Disease Diagnosis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Buerger’s Disease Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Buerger’s Disease Diagnosis.
Report Scope
The Buerger’s Disease Diagnosis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Buerger’s Disease Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Buerger’s Disease Diagnosis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
FUJIFILM Holdings
GE Healthcare
Koninklijke Philips
Pluristem Therapeutics
Shimadzu Corporation
Siemens Healthcare GmbH
Stempeutics Research
Canon Medical Systems Corporation
t2cure GmbH
Segment by Type
Blood Tests
The Allen’s Test
Angiogram
Tissue Biopsy
Others
Segment by Application
Hospitals
Clinics
Medical Research Centers
Academic Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Buerger’s Disease Diagnosis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Buerger’s Disease Diagnosis Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Blood Tests
1.2.3 The Allen’s Test
1.2.4 Angiogram
1.2.5 Tissue Biopsy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Buerger’s Disease Diagnosis Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Medical Research Centers
1.3.5 Academic Institutes
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Buerger’s Disease Diagnosis Market Perspective (2019-2030)
2.2 Buerger’s Disease Diagnosis Growth Trends by Region
2.2.1 Global Buerger’s Disease Diagnosis Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Buerger’s Disease Diagnosis Historic Market Size by Region (2019-2024)
2.2.3 Buerger’s Disease Diagnosis Forecasted Market Size by Region (2025-2030)
2.3 Buerger’s Disease Diagnosis Market Dynamics
2.3.1 Buerger’s Disease Diagnosis Industry Trends
2.3.2 Buerger’s Disease Diagnosis Market Drivers
2.3.3 Buerger’s Disease Diagnosis Market Challenges
2.3.4 Buerger’s Disease Diagnosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Buerger’s Disease Diagnosis Players by Revenue
3.1.1 Global Top Buerger’s Disease Diagnosis Players by Revenue (2019-2024)
3.1.2 Global Buerger’s Disease Diagnosis Revenue Market Share by Players (2019-2024)
3.2 Global Buerger’s Disease Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Buerger’s Disease Diagnosis Revenue
3.4 Global Buerger’s Disease Diagnosis Market Concentration Ratio
3.4.1 Global Buerger’s Disease Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Buerger’s Disease Diagnosis Revenue in 2023
3.5 Buerger’s Disease Diagnosis Key Players Head office and Area Served
3.6 Key Players Buerger’s Disease Diagnosis Product Solution and Service
3.7 Date of Enter into Buerger’s Disease Diagnosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Buerger’s Disease Diagnosis Breakdown Data by Type
4.1 Global Buerger’s Disease Diagnosis Historic Market Size by Type (2019-2024)
4.2 Global Buerger’s Disease Diagnosis Forecasted Market Size by Type (2025-2030)
5 Buerger’s Disease Diagnosis Breakdown Data by Application
5.1 Global Buerger’s Disease Diagnosis Historic Market Size by Application (2019-2024)
5.2 Global Buerger’s Disease Diagnosis Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Buerger’s Disease Diagnosis Market Size (2019-2030)
6.2 North America Buerger’s Disease Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Buerger’s Disease Diagnosis Market Size by Country (2019-2024)
6.4 North America Buerger’s Disease Diagnosis Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Buerger’s Disease Diagnosis Market Size (2019-2030)
7.2 Europe Buerger’s Disease Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Buerger’s Disease Diagnosis Market Size by Country (2019-2024)
7.4 Europe Buerger’s Disease Diagnosis Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Buerger’s Disease Diagnosis Market Size (2019-2030)
8.2 Asia-Pacific Buerger’s Disease Diagnosis Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Buerger’s Disease Diagnosis Market Size by Region (2019-2024)
8.4 Asia-Pacific Buerger’s Disease Diagnosis Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Buerger’s Disease Diagnosis Market Size (2019-2030)
9.2 Latin America Buerger’s Disease Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Buerger’s Disease Diagnosis Market Size by Country (2019-2024)
9.4 Latin America Buerger’s Disease Diagnosis Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Buerger’s Disease Diagnosis Market Size (2019-2030)
10.2 Middle East & Africa Buerger’s Disease Diagnosis Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Buerger’s Disease Diagnosis Market Size by Country (2019-2024)
10.4 Middle East & Africa Buerger’s Disease Diagnosis Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 FUJIFILM Holdings
11.1.1 FUJIFILM Holdings Company Detail
11.1.2 FUJIFILM Holdings Business Overview
11.1.3 FUJIFILM Holdings Buerger’s Disease Diagnosis Introduction
11.1.4 FUJIFILM Holdings Revenue in Buerger’s Disease Diagnosis Business (2019-2024)
11.1.5 FUJIFILM Holdings Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Detail
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Buerger’s Disease Diagnosis Introduction
11.2.4 GE Healthcare Revenue in Buerger’s Disease Diagnosis Business (2019-2024)
11.2.5 GE Healthcare Recent Development
11.3 Koninklijke Philips
11.3.1 Koninklijke Philips Company Detail
11.3.2 Koninklijke Philips Business Overview
11.3.3 Koninklijke Philips Buerger’s Disease Diagnosis Introduction
11.3.4 Koninklijke Philips Revenue in Buerger’s Disease Diagnosis Business (2019-2024)
11.3.5 Koninklijke Philips Recent Development
11.4 Pluristem Therapeutics
11.4.1 Pluristem Therapeutics Company Detail
11.4.2 Pluristem Therapeutics Business Overview
11.4.3 Pluristem Therapeutics Buerger’s Disease Diagnosis Introduction
11.4.4 Pluristem Therapeutics Revenue in Buerger’s Disease Diagnosis Business (2019-2024)
11.4.5 Pluristem Therapeutics Recent Development
11.5 Shimadzu Corporation
11.5.1 Shimadzu Corporation Company Detail
11.5.2 Shimadzu Corporation Business Overview
11.5.3 Shimadzu Corporation Buerger’s Disease Diagnosis Introduction
11.5.4 Shimadzu Corporation Revenue in Buerger’s Disease Diagnosis Business (2019-2024)
11.5.5 Shimadzu Corporation Recent Development
11.6 Siemens Healthcare GmbH
11.6.1 Siemens Healthcare GmbH Company Detail
11.6.2 Siemens Healthcare GmbH Business Overview
11.6.3 Siemens Healthcare GmbH Buerger’s Disease Diagnosis Introduction
11.6.4 Siemens Healthcare GmbH Revenue in Buerger’s Disease Diagnosis Business (2019-2024)
11.6.5 Siemens Healthcare GmbH Recent Development
11.7 Stempeutics Research
11.7.1 Stempeutics Research Company Detail
11.7.2 Stempeutics Research Business Overview
11.7.3 Stempeutics Research Buerger’s Disease Diagnosis Introduction
11.7.4 Stempeutics Research Revenue in Buerger’s Disease Diagnosis Business (2019-2024)
11.7.5 Stempeutics Research Recent Development
11.8 Canon Medical Systems Corporation
11.8.1 Canon Medical Systems Corporation Company Detail
11.8.2 Canon Medical Systems Corporation Business Overview
11.8.3 Canon Medical Systems Corporation Buerger’s Disease Diagnosis Introduction
11.8.4 Canon Medical Systems Corporation Revenue in Buerger’s Disease Diagnosis Business (2019-2024)
11.8.5 Canon Medical Systems Corporation Recent Development
11.9 t2cure GmbH
11.9.1 t2cure GmbH Company Detail
11.9.2 t2cure GmbH Business Overview
11.9.3 t2cure GmbH Buerger’s Disease Diagnosis Introduction
11.9.4 t2cure GmbH Revenue in Buerger’s Disease Diagnosis Business (2019-2024)
11.9.5 t2cure GmbH Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Buerger’s Disease Diagnosis Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Blood Tests
Table 3. Key Players of The Allen’s Test
Table 4. Key Players of Angiogram
Table 5. Key Players of Tissue Biopsy
Table 6. Key Players of Others
Table 7. Global Buerger’s Disease Diagnosis Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Buerger’s Disease Diagnosis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Buerger’s Disease Diagnosis Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Buerger’s Disease Diagnosis Market Share by Region (2019-2024)
Table 11. Global Buerger’s Disease Diagnosis Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Buerger’s Disease Diagnosis Market Share by Region (2025-2030)
Table 13. Buerger’s Disease Diagnosis Market Trends
Table 14. Buerger’s Disease Diagnosis Market Drivers
Table 15. Buerger’s Disease Diagnosis Market Challenges
Table 16. Buerger’s Disease Diagnosis Market Restraints
Table 17. Global Buerger’s Disease Diagnosis Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Buerger’s Disease Diagnosis Market Share by Players (2019-2024)
Table 19. Global Top Buerger’s Disease Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Buerger’s Disease Diagnosis as of 2023)
Table 20. Ranking of Global Top Buerger’s Disease Diagnosis Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Buerger’s Disease Diagnosis Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Buerger’s Disease Diagnosis Product Solution and Service
Table 24. Date of Enter into Buerger’s Disease Diagnosis Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Buerger’s Disease Diagnosis Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Buerger’s Disease Diagnosis Revenue Market Share by Type (2019-2024)
Table 28. Global Buerger’s Disease Diagnosis Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Buerger’s Disease Diagnosis Revenue Market Share by Type (2025-2030)
Table 30. Global Buerger’s Disease Diagnosis Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Buerger’s Disease Diagnosis Revenue Market Share by Application (2019-2024)
Table 32. Global Buerger’s Disease Diagnosis Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Buerger’s Disease Diagnosis Revenue Market Share by Application (2025-2030)
Table 34. North America Buerger’s Disease Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Buerger’s Disease Diagnosis Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Buerger’s Disease Diagnosis Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Buerger’s Disease Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Buerger’s Disease Diagnosis Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Buerger’s Disease Diagnosis Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Buerger’s Disease Diagnosis Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Buerger’s Disease Diagnosis Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Buerger’s Disease Diagnosis Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Buerger’s Disease Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Buerger’s Disease Diagnosis Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Buerger’s Disease Diagnosis Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Buerger’s Disease Diagnosis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Buerger’s Disease Diagnosis Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Buerger’s Disease Diagnosis Market Size by Country (2025-2030) & (US$ Million)
Table 49. FUJIFILM Holdings Company Detail
Table 50. FUJIFILM Holdings Business Overview
Table 51. FUJIFILM Holdings Buerger’s Disease Diagnosis Product
Table 52. FUJIFILM Holdings Revenue in Buerger’s Disease Diagnosis Business (2019-2024) & (US$ Million)
Table 53. FUJIFILM Holdings Recent Development
Table 54. GE Healthcare Company Detail
Table 55. GE Healthcare Business Overview
Table 56. GE Healthcare Buerger’s Disease Diagnosis Product
Table 57. GE Healthcare Revenue in Buerger’s Disease Diagnosis Business (2019-2024) & (US$ Million)
Table 58. GE Healthcare Recent Development
Table 59. Koninklijke Philips Company Detail
Table 60. Koninklijke Philips Business Overview
Table 61. Koninklijke Philips Buerger’s Disease Diagnosis Product
Table 62. Koninklijke Philips Revenue in Buerger’s Disease Diagnosis Business (2019-2024) & (US$ Million)
Table 63. Koninklijke Philips Recent Development
Table 64. Pluristem Therapeutics Company Detail
Table 65. Pluristem Therapeutics Business Overview
Table 66. Pluristem Therapeutics Buerger’s Disease Diagnosis Product
Table 67. Pluristem Therapeutics Revenue in Buerger’s Disease Diagnosis Business (2019-2024) & (US$ Million)
Table 68. Pluristem Therapeutics Recent Development
Table 69. Shimadzu Corporation Company Detail
Table 70. Shimadzu Corporation Business Overview
Table 71. Shimadzu Corporation Buerger’s Disease Diagnosis Product
Table 72. Shimadzu Corporation Revenue in Buerger’s Disease Diagnosis Business (2019-2024) & (US$ Million)
Table 73. Shimadzu Corporation Recent Development
Table 74. Siemens Healthcare GmbH Company Detail
Table 75. Siemens Healthcare GmbH Business Overview
Table 76. Siemens Healthcare GmbH Buerger’s Disease Diagnosis Product
Table 77. Siemens Healthcare GmbH Revenue in Buerger’s Disease Diagnosis Business (2019-2024) & (US$ Million)
Table 78. Siemens Healthcare GmbH Recent Development
Table 79. Stempeutics Research Company Detail
Table 80. Stempeutics Research Business Overview
Table 81. Stempeutics Research Buerger’s Disease Diagnosis Product
Table 82. Stempeutics Research Revenue in Buerger’s Disease Diagnosis Business (2019-2024) & (US$ Million)
Table 83. Stempeutics Research Recent Development
Table 84. Canon Medical Systems Corporation Company Detail
Table 85. Canon Medical Systems Corporation Business Overview
Table 86. Canon Medical Systems Corporation Buerger’s Disease Diagnosis Product
Table 87. Canon Medical Systems Corporation Revenue in Buerger’s Disease Diagnosis Business (2019-2024) & (US$ Million)
Table 88. Canon Medical Systems Corporation Recent Development
Table 89. t2cure GmbH Company Detail
Table 90. t2cure GmbH Business Overview
Table 91. t2cure GmbH Buerger’s Disease Diagnosis Product
Table 92. t2cure GmbH Revenue in Buerger’s Disease Diagnosis Business (2019-2024) & (US$ Million)
Table 93. t2cure GmbH Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Buerger’s Disease Diagnosis Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Buerger’s Disease Diagnosis Market Share by Type: 2023 VS 2030
Figure 3. Blood Tests Features
Figure 4. The Allen’s Test Features
Figure 5. Angiogram Features
Figure 6. Tissue Biopsy Features
Figure 7. Others Features
Figure 8. Global Buerger’s Disease Diagnosis Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Buerger’s Disease Diagnosis Market Share by Application: 2023 VS 2030
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Medical Research Centers Case Studies
Figure 13. Academic Institutes Case Studies
Figure 14. Others Case Studies
Figure 15. Buerger’s Disease Diagnosis Report Years Considered
Figure 16. Global Buerger’s Disease Diagnosis Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Buerger’s Disease Diagnosis Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Buerger’s Disease Diagnosis Market Share by Region: 2023 VS 2030
Figure 19. Global Buerger’s Disease Diagnosis Market Share by Players in 2023
Figure 20. Global Top Buerger’s Disease Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Buerger’s Disease Diagnosis as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Buerger’s Disease Diagnosis Revenue in 2023
Figure 22. North America Buerger’s Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Buerger’s Disease Diagnosis Market Share by Country (2019-2030)
Figure 24. United States Buerger’s Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Buerger’s Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Buerger’s Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Buerger’s Disease Diagnosis Market Share by Country (2019-2030)
Figure 28. Germany Buerger’s Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Buerger’s Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Buerger’s Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Buerger’s Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Buerger’s Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Buerger’s Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Buerger’s Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Buerger’s Disease Diagnosis Market Share by Region (2019-2030)
Figure 36. China Buerger’s Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Buerger’s Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Buerger’s Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Buerger’s Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Buerger’s Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Buerger’s Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Buerger’s Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Buerger’s Disease Diagnosis Market Share by Country (2019-2030)
Figure 44. Mexico Buerger’s Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Buerger’s Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Buerger’s Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Buerger’s Disease Diagnosis Market Share by Country (2019-2030)
Figure 48. Turkey Buerger’s Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Buerger’s Disease Diagnosis Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. FUJIFILM Holdings Revenue Growth Rate in Buerger’s Disease Diagnosis Business (2019-2024)
Figure 51. GE Healthcare Revenue Growth Rate in Buerger’s Disease Diagnosis Business (2019-2024)
Figure 52. Koninklijke Philips Revenue Growth Rate in Buerger’s Disease Diagnosis Business (2019-2024)
Figure 53. Pluristem Therapeutics Revenue Growth Rate in Buerger’s Disease Diagnosis Business (2019-2024)
Figure 54. Shimadzu Corporation Revenue Growth Rate in Buerger’s Disease Diagnosis Business (2019-2024)
Figure 55. Siemens Healthcare GmbH Revenue Growth Rate in Buerger’s Disease Diagnosis Business (2019-2024)
Figure 56. Stempeutics Research Revenue Growth Rate in Buerger’s Disease Diagnosis Business (2019-2024)
Figure 57. Canon Medical Systems Corporation Revenue Growth Rate in Buerger’s Disease Diagnosis Business (2019-2024)
Figure 58. t2cure GmbH Revenue Growth Rate in Buerger’s Disease Diagnosis Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
